logo

For the Inventor, By the Inventor

Solna, Sweden

Xspray Pharma Ab

USPTO Granted Patents = 18


Forward Citations = 18

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Magnus Brisander (9 out of 23 patents)

silverMedal Thomas Meijer (9 out of 12 patents)

bronzeMedal Victor Söderberg (9 out of 10 patents)

4.  Gérald Jesson (8 out of 20 patents)

5.  Martin Malmsten (8 out of 20 patents)

6.  Helene Dérand (8 out of 20 patents)

7.  Mustafa Demirbüker (8 out of 22 patents)

8.  Per X Andersson (8 out of 40 patents)

9.  Andreas Fischer (1 out of 16 patents)

10.  Thomas Andersson (1 out of 1 patent)

11.  Mustafa DEMIRBÛKER (0 patent)


18 patents:

1. 12576071 - Pharmaceutical compositions (2026-03-17),
2. 12419892 - Pharmaceutical compositions comprising nilotinib (2025-09-23),
3. 12144804 - Pharmaceutical compositions (2024-11-19),
4. 12076314 - Pharmaceutical compositions (2024-09-03),
5. 11963951 - Pharmaceutical compositions (2024-04-23),
6. 11833249 - Rapidly disintegrating solid oral dosage forms containing dasatinib (2023-12-05),
7. 11529351 - Fast dissolving pharmaceutical compositions (2022-12-20),
8. 11517562 - Pharmaceutical compositions (2022-12-06),
9. 11426391 - Pharmaceutical compositions (2022-08-30),
10. 11376243 - Pharmaceutical compositions (2022-07-05),
11. 11344500 - Rapidly disintegrating solid oral dosage forms containing dasatinib (2022-05-31),
12. 11241419 - Pharmaceutical compositions (2022-02-08),
13. 10894018 - Rapidly disintegrating solid oral dosage forms containing dasatinib (2021-01-19),
14. 10894017 - Rapidly disintegrating solid oral dosage forms containing dasatinib (2021-01-19),
15. 10874614 - Rapidly disintegrating solid oral dosage forms containing dasatinib (2020-12-29),
Company Overview
Xspray Pharma AB is a pharmaceutical company based in Solna, Sweden, specializing in the development of innovative drug delivery systems. The company focuses on enhancing the bioavailability of existing drugs through its proprietary technology, which aims to improve therapeutic outcomes for patients. Xspray Pharma's research primarily targets oncology and other therapeutic areas, leveraging its expertise in formulation development to create more effective treatments. The organization is committed to advancing healthcare through its novel approaches in drug formulation.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

18 Patents

#13 in Solna

#365 in Sweden

#34,244 in the World

Solna, SE
Solna, Sweden

Xspray Pharma Ab

Forward Citations = 18

10 inventors:

goldMedal Magnus Brisander (9 out of 23 patents)

silverMedal Thomas Meijer (9 out of 12 patents)

bronzeMedal Victor Söderberg (9 out of 10 patents)

4.  Gérald Jesson (8 out of 20 patents)

5.  Martin Malmsten (8 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Xspray Pharma Ab. Retrieved from https://idiyas.com/company/xspray-pharma-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…